Skip to Main Content
S. Karger AG
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 5, Issue 4
October – December 2005
Issue Cover
All Issues
ISSN 1422-9528
EISSN 1424-0556
In this Issue

Journal Name Change

Merged with Vol. 6 (2006) into: Cardiology.

Heart Drug 2005, Vol. 5, No. 4

Clinical Trial

Safety of Bone Marrow Stem Cell Mobilization Induced by Granulocyte-Colony Stimulating Factor: 30 Days’ Blinded Clinical Results from the Stem Cells in Myocardial Infarction (STEMMI) Trial
Rasmus Sejersten Ripa; Yongzhong Wang; Erik Jørgensen; Hans E. Johnsen; Peer Grande; Jens Kastrup
Heart Drug (2005) 5 (4): 177–182. https://doi.org/10.1159/000089596
View articletitled, Safety of Bone Marrow Stem Cell Mobilization Induced by Granulocyte-Colony Stimulating Factor: 30 Days’ Blinded Clinical Results from the Stem Cells in Myocardial Infarction (STEMMI) Trial
Open the PDF for in another window

Clinical Study

Can Statins Be Considered as a Tertiary Level Agent in Patients with Failure of Conventional Oral Hypoglycemic Agents?
Vijay Prabhakar; P.V. Krishna Kishore; Madhuri Balaji; V. Balaji; V. Seshaiah
Heart Drug (2005) 5 (4): 183–186. https://doi.org/10.1159/000089597
View articletitled, Can Statins Be Considered as a Tertiary Level Agent in Patients with Failure of Conventional Oral Hypoglycemic Agents?
Open the PDF for in another window
Comparison of Ticlopidine and Aspirin versus Clopidogrel and Aspirin after Percutaneous Coronary Interventions in High-Risk Patients: A Double-Blind Randomized Study
Pietro Di Pasquale; Sergio Cannizzaro; Sebastiano Scalzo; Francesco Giambanco; Giuseppe Tricoli; Sergio Fasullo; Salvatore Paterna
Heart Drug (2005) 5 (4): 187–192. https://doi.org/10.1159/000089598
View articletitled, Comparison of Ticlopidine and Aspirin versus Clopidogrel and Aspirin after Percutaneous Coronary Interventions in High-Risk Patients<span class="subtitle-colon">: </span><span class="subtitle">A Double-Blind Randomized Study</span>
Open the PDF for in another window
Rationale and Design of the OACIS-LIPID Study That Evaluates Early Use of Pravastatin in Acute Myocardial Infarction
Yasuhiko Sakata; Hiroshi Sato; Kunihiro Kinjo; Kenshi Fujii; Kazuhisa Kodama; Jun Tanouchi; Masayoshi Mishima; Hideo Kusuoka; Daisaku Nakatani; Hiroya Mizuno; Masahiko Shimizu; Masatsugu Hori
Heart Drug (2005) 5 (4): 193–196. https://doi.org/10.1159/000089599
View articletitled, Rationale and Design of the OACIS-LIPID Study That Evaluates Early Use of Pravastatin in Acute Myocardial Infarction
Open the PDF for in another window
Hyperglycemia after Acute Ischemic Stroke: Prediction, Significance and Immediate Control with Insulin-Potassium-Saline-Magnesium Infusions
Stephan M. Vinychuk; Volodymyr S. Melnyk; Victor M. Margitich
Heart Drug (2005) 5 (4): 197–204. https://doi.org/10.1159/000089600
View articletitled, Hyperglycemia after Acute Ischemic Stroke: Prediction, Significance and Immediate Control with Insulin-Potassium-Saline-Magnesium Infusions
Open the PDF for in another window

Review

Scientific Basis of Cardio-Pulmonary Resuscitation, an Evidence-Based Review
Martin von Planta
Heart Drug (2005) 5 (4): 205–213. https://doi.org/10.1159/000089601
View articletitled, Scientific Basis of Cardio-Pulmonary Resuscitation, an Evidence-Based Review
Open the PDF for in another window
Inhibition of the Renin-Angiotensin System and Atrial Fibrillation in Heart Failure
Maryse Palardy; Anique Ducharme
Heart Drug (2005) 5 (4): 214–219. https://doi.org/10.1159/000089602
View articletitled, Inhibition of the Renin-Angiotensin System and Atrial Fibrillation in Heart Failure
Open the PDF for in another window
Nicorandil – Review of Pharmacological Properties and Clinical Applications
Jean-Paul Schmid; Verena Schroeder
Heart Drug (2005) 5 (4): 220–229. https://doi.org/10.1159/000089603
View articletitled, Nicorandil – Review of Pharmacological Properties and Clinical Applications
Open the PDF for in another window

Further Section

Author Index Vol. 5, 2005
Heart Drug (2005) 5 (4): 230. https://doi.org/10.1159/000090324
View articletitled, Author Index Vol. 5, 2005
Open the PDF for in another window
Subject Index Vol. 5, 2005
Heart Drug (2005) 5 (4): 231. https://doi.org/10.1159/000090325
View articletitled, Subject Index Vol. 5, 2005
Open the PDF for in another window
Contents Vol. 5, 2005
Heart Drug (2005) 5 (4): 232. https://doi.org/10.1159/000090326
View articletitled, Contents Vol. 5, 2005
Open the PDF for in another window
Subject Index Vol. 5, 2005
Comparison of Ticlopidine and Aspirin versus Clopidogrel and Aspirin after Percutaneous Coronary Interventions in High-Risk Patients: A Double-Blind Randomized Study
Nicorandil – Review of Pharmacological Properties and Clinical Applications
Inhibition of the Renin-Angiotensin System and Atrial Fibrillation in Heart Failure
  • Online ISSN 1424-0556
  • Print ISSN 1422-9528
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal